148 related articles for article (PubMed ID: 34220332)
1. Antitumor Activity of Small Activating RNAs Induced PAWR Gene Activation in Human Bladder Cancer Cells.
Yang K; Shen J; Tan FQ; Zheng XY; Xie LP
Int J Med Sci; 2021; 18(13):3039-3049. PubMed ID: 34220332
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
Yang K; Shen J; Chen SW; Qin J; Zheng XY; Xie LP
Oncol Rep; 2016 Apr; 35(4):2487-93. PubMed ID: 26797252
[TBL] [Abstract][Full Text] [Related]
3. Promoter-targeted double-stranded small RNAs activate PAWR gene expression in human cancer cells.
Yang K; Shen J; Xie YQ; Lin YW; Qin J; Mao QQ; Zheng XY; Xie LP
Int J Biochem Cell Biol; 2013 Jul; 45(7):1338-46. PubMed ID: 23583662
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells.
Yang K; Zheng XY; Qin J; Wang YB; Bai Y; Mao QQ; Wan Q; Wu ZM; Xie LP
Cancer Lett; 2008 Jul; 265(2):206-14. PubMed ID: 18358601
[TBL] [Abstract][Full Text] [Related]
5. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
Ho JN; Byun SS; Lee SE; Youn JI; Lee S
Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells.
Mao Q; Li Y; Zheng X; Yang K; Shen H; Qin J; Bai Y; Kong D; Jia X; Xie L
Biochem Biophys Res Commun; 2008 Oct; 375(4):566-70. PubMed ID: 18725195
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.
Li C; Liu J; Zhang Q; Cui K; Ge Q; Wang C; Chen Z
Int J Oncol; 2018 Jun; 52(6):1815-1826. PubMed ID: 29620261
[TBL] [Abstract][Full Text] [Related]
8. Small activating RNA induced expression of VHL gene in renal cell carcinoma.
Kang MR; Park KH; Lee CW; Lee MY; Han SB; Li LC; Kang JS
Int J Biochem Cell Biol; 2018 Apr; 97():36-42. PubMed ID: 29425832
[TBL] [Abstract][Full Text] [Related]
9. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.
Rah B; ur Rasool R; Nayak D; Yousuf SK; Mukherjee D; Kumar LD; Goswami A
Autophagy; 2015; 11(2):314-31. PubMed ID: 25803782
[TBL] [Abstract][Full Text] [Related]
10. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
11. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma.
Ho IL; Kuo KL; Liu SH; Chang HC; Hsieh JT; Wu JT; Chiang CK; Lin WC; Tsai YC; Chou CT; Hsu CH; Pu YS; Shi CS; Huang KH
Sci Rep; 2015 Nov; 5():16948. PubMed ID: 26592553
[TBL] [Abstract][Full Text] [Related]
12. Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.
Li C; Jiang W; Hu Q; Li LC; Dong L; Chen R; Zhang Y; Tang Y; Thrasher JB; Liu CB; Li B
Oncotarget; 2016 Apr; 7(16):22893-910. PubMed ID: 27014974
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of bladder cancer by sodium butyrate and cisplatin.
Maruyama T; Yamamoto S; Qiu J; Ueda Y; Suzuki T; Nojima M; Shima H
J Infect Chemother; 2012 Jun; 18(3):288-95. PubMed ID: 22041988
[TBL] [Abstract][Full Text] [Related]
14. The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.
Plissonnier ML; Fauconnet S; Bittard H; Lascombe I
PLoS One; 2011; 6(12):e28354. PubMed ID: 22174792
[TBL] [Abstract][Full Text] [Related]
15. Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression.
Wang C; Ge Q; Chen Z; Hu J; Li F; Ye Z
Tumour Biol; 2016 May; 37(5):6589-98. PubMed ID: 26643891
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells.
Earel JK; VanOosten RL; Griffith TS
Cancer Res; 2006 Jan; 66(1):499-507. PubMed ID: 16397266
[TBL] [Abstract][Full Text] [Related]
17. β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas.
Li QQ; Wang G; Liang H; Li JM; Huang F; Agarwal PK; Zhong Y; Reed E
Anticancer Res; 2013 Apr; 33(4):1421-8. PubMed ID: 23564782
[TBL] [Abstract][Full Text] [Related]
18. NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells.
Moon du G; Lee SE; Oh MM; Lee SC; Jeong SJ; Hong SK; Yoon CY; Byun SS; Park HS; Cheon J
Int J Oncol; 2014 Sep; 45(3):1027-35. PubMed ID: 24969552
[TBL] [Abstract][Full Text] [Related]
19. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
20. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
